《Drug Resistance in Cancer Cells》是一本圖書，作者是Mehta, Kapil (EDT)
基本介紹
- 外文名：Drug Resistance in Cancer Cells
- 作者：Mehta, Kapil (EDT)
- 出版時間：2009年6月
- 頁數：380 頁
- ISBN：9780387894447
- 定價：202.27 美元
Drug Resistance in Cancer Cells
相關詞條
- Drug Resistance in Cancer
Drug Resistance in Cancer 《Drug Resistance in Cancer》是一本圖書，作者是Goldie, J. H.; Goldie, James H.; Coldman, Andrew J.
- Drug Resistance in Cancer Therapy
Drug Resistance in Cancer Therapy 《Drug Resistance in Cancer Therapy》是一本圖書，作者是Ozols, Robert F.
- CELL(1974年首次發刊的《細胞》期刊)
2024年8月27日，上海大學醫學院卞月珉教授與美國哈佛大學醫學院Jonathan Abraham教授團隊合作，作為共同第一作者，在國際頂級期刊《Cell》（《細胞》）上發表題為《Viral DNA polymerase structures reveal mechanisms of antiviral drug resistance》的研究論文。2024年9月，上海交通大學醫學院腫瘤系統醫學全國重點實驗室沈...
- Drug Resistance in the Treatment of Cancer(圖書)
Drug Resistance in the Treatment of Cancer 《Drug Resistance in the Treatment of Cancer》是一本圖書，作者是Pinedo, Herbert M.; Giaccone, Giuseppe; Sikora, Karol
- Drug Resistance in the Treatment of Cancer(Pinedo, Herbert M.; G...
and most of the remaining half develop drug resistance during the course of their treatment. This book reviews the mechanisms and clinical implications of drug resistance in cancer with unrivalled authority. Chapters cover topics of current clinical concern, including multiple drug resistance and its ...
- 袁中玉(中山大學腫瘤防治中心內科主任醫師、博士生導師)
(23) Zou Zhengzhi, Zhang Qiongxia, Long Zijie, Chen, Yuan Zhongyu Jinna Tang, Zhiping Zhu Yuliang, Chen Shupeng, Xu Jie, Yan Min, Wang Jing, Liu Quentin(*), Aurora kinase A inhibition-induced autophagy triggers drug resistance in breast cancer cells.,Autophagy,2012,8(12):1798-1810.(24...
- 癌幹細胞
耐藥性(drugresistance)是癌幹細胞的特性之一，因而認為癌幹細胞的存在是導致腫瘤化療失敗的主要原因。正常情況下，多數耐藥分子在營養吸收的器官組織(如肺、消化道)、代謝和排泄器官組織(肝、腎)等的上皮細胞均有不同程度的表達，同時這些運輸分子在維持體內的生理屏障(血腦屏障、血腦脊髓液屏障、血睪屏障、母體－...
- 石智
36.ShiZ, Jain S, Kim IW, Peng XX, Abraham I, FuLW*, YoussefDTA, El SayedKA, AmbudkarSV, ChenZS*. Sipholenol A, a marine-derived sipholane triterpene, potently reverses P-glycoprotein (ABCB1)-mediated multidrug resistance in cancer cells.Cancer Sci.2007 Sep;98(9):1373-80.(SCI IF:...
- 何冬旭
，Zou, Chang，Zhang, Peng，Lo,He, Dongxu(並列第一)Chun Yin，Xu, Zhenyu，Chan, Franky L.，Yu, Shan，Chen, Yun，Zhu, Ruiyu，Lei,Jianyong，Jin, Jian(*)，Yao, Xiaoqiang(*)，Transient receptor potential channel TRPC5 is essential for P-glycoprotein induction in drug-resistant cancer cells，...
- 劉定斌
1.Wang Z,? Wang Z,? Liu D,? Yan X, Wang F, Niu G, Yang M, Chen X. Biomimetic RNA-Silencing Nanocomplexes: Overcoming Multidrug Resistance in Cancer Cells. Angew. Chem. Int. Ed., 2014, 53, 1997. (? co-first authors) (IF 11.26)2.Liu D, Wang Z, Jin A, Huang X, Sun X...
- 芮蒙傑
7. Mengjie Rui#, Yang Qu, Tong Gao, Yanru Ge, Chunlai Feng*, and Ximing Xu*. Simultaneous delivery of anti-miR21 with doxorubicin prodrug by mimetic lipoprotein nanoparticles for synergistic effect against drug resistance in cancer cells, International Journal of Nanomedicine, 2017 8. Mengjie Rui...
- 梁玉璐(南開大學化學學院研究員)
1.Wang Z,? Wang Z,? Liu D,? Yan X, Wang F, Niu G, Yang M, Chen X. Biomimetic RNA-Silencing Nanocomplexes: Overcoming Multidrug Resistance in Cancer Cells. Angew. Chem. Int. Ed., 2014, 53, 1997. (? co-first authors) (IF 11.26)2.Liu D, Wang Z, Jin A, Huang X, Sun X...
- 李毅寧
李毅寧，福建醫科大學附屬第二醫院職工。人物事件 2021年12月，福建醫科大學附屬第二醫院李毅寧為通訊作者的論文“Targeted regulation of miR-195 on MAP2K1 for suppressing ADM drug resistance in prostate cancer cells”。經調查，該論文存在篡改圖表數據行為。對張建育作出如下處理：給予黨紀警告處分，取消碩士研究...
- 張秋萍(武漢大學基礎醫學院教授)
[8] Chao-Hua Deng, Qiuping Zhang(通訊作者). Leukemia stem cells in drug resistance and metastasis Chin Med J., 2010;123(7):954-960 專利：一種重組免疫毒素CCL25-PE38基因及製備方法和套用，申請號：201110001125.2（張秋萍，胡義，張莉）發現了趨化性細胞因子受體9（CCR9）及其配體CCL25與急性T淋巴...
- 腫瘤研究前沿(第14卷)
綜述二 Drug resistance related miRNAs in hepatocellular cancer 綜述三 Epigenetic regulation of microRNAs in gastric cancer 綜述四 Multi- drug resistance in cancer chemotherapeutics: mechanisms and lab approaches 綜述五 The epithelial- mesenchymal transition and cancer stem cells: function and mechanism links...
- 黃燦華
9. Jin P, Jiang J, Zhou L, Huang Z, Nice EC, Huang C*, Fu L*. Mitochondrial adaptation in cancer drug resistance: prevalence, mechanisms, and management. J Hematol Oncol . 2022;15,97.10. Tian H, Zhou L, Wang Y, Nice EC, Huang C*, Zhang H*. A targeted nanomodulator capable ...
- 李湘奇
Determinationof the migration effect and molecular docking of verteporfin in differentsubtypes of breast cancer cells The Role ofPhotoactivated and Non-Photoactivated Verteporfin on Tumor NVP-CGM097, anHDM2Inhibitor,Antagonizes ATP-Binding Cassette Subfamily B Member1-Mediated Drug Resistance Frontiers in...
- 何強(中山大學附屬第一醫院肝外科主任醫師)
3. Alaoui-Jamali MA, Dupré I, Qiang H. Prediction of drug sensitivity and drug resistance in cancer by transcriptional and proteomic profiling. Drug Resist Updat. 2004 Aug-Oct;7(4-5):245-55.4. Xu Y, Benlimame N, Su J, He Q, Alaoui-Jamali MA. Regulation of focal adhesion turn...
- 武正華(上海交通大學藥學院碩士導師)
（IF：3.033）11. Zheqi Li, Lingyun Hu, Hao Chen, Qi Zhu, Zhenghua Wu and Dawei Li, Anterior gradient 2 is a binding stabilizer of HIF-1α that enhances CoCl2-induced doxorubicin resistance in breast cancer cells, Cancer Science, 2015.6.17, 106(8): 1041-1049. （IF：6.649）
- 葉茂(湖南大學生物學院教授)
Peng, Yongbo#; Zhao, Zilong#; Liu, Teng#; Xie, Guojian; Jin, Cheng; Deng, Tang gang; Sun, Yang; Li, Xiong; Hu, Xiaoxiao; Zhang, Xiaobing; Ye, Mao; Tan, Weihong*. A Multi﹊tochondrial Anticancer Agent that Selectively Kills Cancer Cells and Overcomes Drug Resistance, ChemMedChem, ...
- 張曉芳(山東大學基礎醫學院講師)
Xiaofang Zhang, Juan Li, Zhengang Qiu, Xiaojuan Wu, Peng Gao, Genyin Zhou(*).Co-suppression of MDR1 (multidrug resistence 1) and GCS (glucosylceramide synthase) restores sensitivity to mutidrug resistance breast cancer cells by RNA interference (RNAi). Cancer Biol Ther. 2009; 8(12): ...
- 劉鑫(武漢大學藥學院教授)
Ai S, Jia T, Ai W, Duan J, Liu Y, Chen J, Liu X, Yang F, Tian Y, Huang Z. Targeted delivery of doxorubicin through conjugation with EGF receptor-binding peptide overcomes drug resistance in human colon cancer cells. Br J Pharmacol. 2013 Apr;168(7):1719-35 (19) Ai S, ...
- 陳寶安(全國知名血液病與腫瘤學專家)
7.LiK, Chen BA*,Xu L, Feng J, Xia G, Cheng Jet al.Reversal of multidrug resistance by cisplatin-loaded magnetic Fe3O4nanoparticles in A549/DDP lung cancer cells in vitro and in vivo. Int J Nanomedicine 2013; 8: 1867-1877.8.LiangG, Li J, Sun B, Li S, Lu L, Wang Y, Chen ...
- 萬升標
7. Zhang,P.Y.; Wong, I.L.; Yan, C.S.; Zhang, X.Y.; Jiang, T.; Chow, L.M.; Wan, S.B*. Design and syntheses of permethyl ningalin B analogues: Potent multidrug resistance (MDR) reversal agents of cancer cells. J. Med. Chem. 2010, 53, 5108–5120. (IF=5.20).8. Yang...
- 21世紀大學醫學英語:基礎醫學英語
Passage B HIV in Older Adults Unit 13 Section A Terminology Section B Passages Passage A Genetic Transfer Mechanisms and the Transmission of Drug Resistance in Bacteria Passage B Genetic Counseling Unit 14 Section A Terminology Section B Passages Passage A Definition and Nature of Inflammation Passage...
- 趙子龍(湖南大學化學化工學院副教授)
[9]. Yongbo Peng#, Zilong Zhao#, Teng Liu#, Guojian Xie, Cheng Jin, Tanggang Deng, Yang Sun, Xiong Li, Xiaoxiao Hu, Xiaobing Zhang, Mao Ye, Weihong Tan*, A Multi-Mitochondrial Anticancer Agent that Selectively Kills Cancer Cells and Overcomes Drug Resistance, ChemMedChem, 2017, 12(3)...
- 巢暉(中山大學教授)
Jinquan Wang, Donglei Zhao, Liangnian Ji, Hui Chao*, “Cyclometalated Ruthenium(II)Anthraquinone Complexes ExhibitStrong Anticancer Activity inHypoxic Tumor Cells”,Chem. Eur. J., 21 (2015) 15308-15319. (Hot paper, Highlight on ChemistryViews “Combating Drug Resistance in Hypoxic Tumor Cells”...
- 朱師達
Zhu S（朱師達）, Thomsen MB, Nielsen RL,Liu D, Wang G, Hou Y, Zhang X, Xu X, Bolund L, Yang H, Wang J, Moreira J,Ditzel HJ, Brünner N, Schrohl AS, Stenvang J, Gupta R. The stepwise evolutionof the exome during acquisition of docetaxel resistance in breast cancer cells.BMC ...
